Wuxi AstraZeneca CICC Venture Capital Partnership Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
21
- Portfolio
-
16
- Exits
-
3
Wuxi AstraZeneca CICC Venture Capital Partnership General Information
Company Description
Wuxi AstraZeneca CICC Venture Capital Partnership is a venture capital firm based in Wuxi, China
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- Room 808, 8th Floor
- Number 99-2 Linghu Avenue, Xinwu District
- Wuxi, Jiangsu
- China
Wuxi AstraZeneca CICC Venture Capital Partnership Investments (21)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycogene | 02-Feb-2026 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Syneron | 11-Dec-2025 | Drug Discovery | Generating Revenue | |||
| SonoSilicon | 10-Dec-2025 | Diagnostic Equipment | Generating Revenue | |||
| Newrite Medical | 10-Oct-2025 | Drug Discovery | Generating Revenue | |||
| YolTech Therapeutics | 10-Sep-2025 | Drug Discovery | Generating Revenue | |||
| Danatlas | 03-Mar-2025 | Drug Discovery | Generating Revenue | |||
| Cholesgen Pharmaceutical | 18-Oct-2024 | Drug Discovery | Product Development | |||
| ETERN Therapeutics | 01-Apr-2024 | Drug Discovery | Generating Revenue | |||
| KYF (Pharmaceuticals) | 14-Oct-2023 | Later Stage VC | Pharmaceuticals | Profitable | ||
| Cholesgen Pharmaceutical | 30-May-2023 | Early Stage VC | Drug Discovery | Product Development |
Wuxi AstraZeneca CICC Venture Capital Partnership Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cullgen | 04-May-2026 | Merger/Acquisition | |
| ZSHK Lab | 14-Apr-2026 |
Wuxi AstraZeneca CICC Venture Capital Partnership Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Wuxi AstraZeneca CICC Venture Capital Partnership Co-Investors (69)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HSG (Hong Kong) | 3 |
|
|
||
| 5Y Capital |
|
|
|||
| CICC Capital |
|
|
|||
| Panlin Capital |
|
|
|||
| Wuxi Capital Group |
|
|
Wuxi AstraZeneca CICC Venture Capital Partnership FAQs
-
What is Wuxi AstraZeneca CICC Venture Capital Partnership?
Wuxi AstraZeneca CICC Venture Capital Partnership is a venture capital firm based in Wuxi, China
-
When was Wuxi AstraZeneca CICC Venture Capital Partnership founded?
Wuxi AstraZeneca CICC Venture Capital Partnership was founded in 2020.
-
Where is Wuxi AstraZeneca CICC Venture Capital Partnership headquartered?
Wuxi AstraZeneca CICC Venture Capital Partnership is headquartered in Wuxi, China.
-
How many investments has Wuxi AstraZeneca CICC Venture Capital Partnership made?
Wuxi AstraZeneca CICC Venture Capital Partnership has made 21 investments.
-
What has Wuxi AstraZeneca CICC Venture Capital Partnership invested in?
Wuxi AstraZeneca CICC Venture Capital Partnership has made numerous investments in companies like Glycogene, Syneron, and SonoSilicon within the Biotechnology, Drug Discovery, and Diagnostic Equipment industries.
-
What has Wuxi AstraZeneca CICC Venture Capital Partnership invested in recently?
Wuxi AstraZeneca CICC Venture Capital Partnership's latest investment was on 02-Feb-2026 in Glycogene, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
